GlassScriptPhysician profile
Terry Sherraden
NPI 1629003207
$1,804.62
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,642 · 2020: $138 · 2021: $24.26.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $284.85 | 2019 | |
| Lilly USA, LLC | $272.11 | 2019-2020 | |
| Amgen INC. | $222.86 | 2019 | |
| Abbott Laboratories | $159.29 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $144.97 | 2019 | |
| Valeritas, INC. | $124.72 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.73 | 2019 | |
| Merck Sharp & Dohme LLC | $79.82 | 2019 | |
| Novo Nordisk INC | $74.74 | 2019 | |
| Janssen Pharmaceuticals, INC | $70.92 | 2019-2020 | |
| Sanofi Pasteur INC. | $59.50 | 2019 | |
| Abbvie INC. | $45.21 | 2019 | |
| Tandem Diabetes Care, INC. | $32.61 | 2019 | |
| Horizon Therapeutics Plc | $24.26 | 2021 | |
| Radius Health, INC. | $18.71 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Companion Medical, INC. | $15.72 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.72 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $14.70 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $14.09 | 2019 | |
| Shire North American Group INC | $13.20 | 2019 | |
| Lifescan, INC. | $13.06 | 2019 | |
| Medtronic Minimed, INC. | $11.83 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Sherraden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.